The histone deacetylase (HDAC) inhibitor valproic acid reduces ethanol consumption and ethanol-conditioned place preference in rats

Brain Research

Volumn 1583, Issue 1, 2014, Pages 122-131

  Al Ameri, Mouza ^a   Al Mansouri, Shamma ^a   Al Maamari, Alyazia ^a   Bahi, Amine ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

CPP; Ethanol; Histone deacetylase; Two bottle choice; Valproic acid

Indexed keywords

ALCOHOL; HISTONE DEACETYLASE INHIBITOR; QUININE; SACCHARIN; VALPROIC ACID; CENTRAL DEPRESSANT AGENT; DRINKING WATER;

ADULT; ALCOHOL BLOOD LEVEL; ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REINFORCEMENT; TASTE ACUITY; ANIMAL; BLOOD; CONDITIONING; DECISION MAKING; DEPTH PERCEPTION; DOSE RESPONSE; DRINKING; DRINKING BEHAVIOR; DRUG EFFECTS; DRUG THERAPY; PATHOPHYSIOLOGY; PHYSIOLOGY; TASTE; WISTAR RAT;

MUS; RATTUS;

ALCOHOL DRINKING; ANIMALS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CHOICE BEHAVIOR; CONDITIONING (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING; DRINKING WATER; ETHANOL; HISTONE DEACETYLASE INHIBITORS; MALE; NUCLEUS ACCUMBENS; QUININE; RATS, WISTAR; SACCHARIN; SPACE PERCEPTION; TASTE PERCEPTION; VALPROIC ACID;

EID: 84922626110     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2014.07.051     Document Type: Article

References (52)

1. Addolorato, G., Leggio, L., 2010. Safety and efficacy of baclofen in the treatment of alcohol-dependent patients. Curr. Pharm. Des. 16, 2113-2117.
2. Archer, T., et al., 2013. Epigenetic modulation of mood disorders. J. Genet. Syndr. Gene Ther. 4, 1000120.
3. Arent, C.O., et al., 2011. Neuroanatomical profile of antimaniac effects of histone deacetylases inhibitors. Mol. Neurobiol. 43, 207-214.
4. Arora, D.S., et al., 2013. Hyposensitivity to gamma-aminobutyric acid in the ventral tegmental area during alcohol withdrawal: reversal by histone deacetylase inhibitors. Neuropsychopharmacology 38, 1674-1684.
5. Bahi, A., 2013. Viral-mediated knockdown of mGluR7 in the nucleus accumbens mediates excessive alcohol drinking and increased ethanol-elicited conditioned place preference in rats. Neuropsychopharmacology 38, 2109-2119.
6. Bahi, A., Dreyer, J.L., 2012. Involvement of nucleus accumbens dopamine D1 receptors in ethanol drinking, ethanol-induced conditioned place preference, and ethanol-induced psychomotor sensitization in mice. Psychopharmacology (Berlin) 222, 141-153.
7. Bahi, A., Dreyer, J.L., 2013. Striatal modulation of BDNF expression using microRNA124a-expressing lentiviral vectors impairs ethanol- induced conditioned-place preference and voluntary alcohol consumption. Eur. J. Neurosci. 38, 2328-2337.
8. Bahi, A., Dreyer, J.L., 2014. Chronic psychosocial stress causes delayed extinction and exacerbates reinstatement of ethanol- induced conditioned place preference in mice. Psychopharmacology (Berlin) 231, 367-377.
9. Bahi, A., et al., 2012. Pharmacological modulation of mGluR7 with AMN082 and MMPIP exerts specific influences on alcohol consumption and preference in rats. Addict. Biol. 17, 235-247.
10. Bahi, A., et al., 2013a. Influence of the novel histamine H(3) receptor antagonist ST1283 on voluntary alcohol consumption and ethanol-induced place preference in mice. Psychopharmacology (Berlin) 228, 85-95.
11. Bahi, A., et al., 2013b. Ghrelin knockout mice show decreased voluntary alcohol consumption and reduced ethanol-induced conditioned place preference. Peptides 43, 48-55.
12. Cousins, M.S., et al., 2002. GABA(B) receptor agonists for the treatment of drug addiction: A review of recent findings. Drug Alcohol Depend. 65, 209-220.
13. Crabbe, J.C., et al., 1996. Elevated alcohol consumption in null mutant mice lacking 5-HT1B serotonin receptors. Nat. Genet. 14, 98-101.
14. Crepaldi, L., Riccio, A., 2009. Chromatin learns to behave (United States). Epigenetics 4, 23-26.
15. Dalton, V.S., et al., 2014. Epigenetics and depression: return of the repressed. J Affect Disord. 155, 1-12.
16. deRuijter, A.J., et al., 2003. Histone deacetylases (HDACs): characterization of the classical HDAC family (England). Biochem J. 370, 737-749.
17. Dombrowski, P.A., et al., 2006. Picrotoxin blocks the anxiolytic- And panicolytic-like effects of sodium valproate in the rat elevated T-maze. Eur. J. Pharmacol. 537, 72-76.
18. Feng, W., et al., 2014. Therapeutic potential of histone deacetylase inhibitors in pancreatic cancer. Cancer Lett..
19. Hodes, G.E., 2013. Sex, stress, and epigenetics: regulation of behavior in animal models of mood disorders (England). Biol. Sex Differ. 4, 1.
20. Host, L., et al., 2011. Cocaine self-administration alters the expression of chromatin-remodelling proteins; modulation by histone deacetylase inhibition. J. Psychopharmacol. 25, 222-229.
21. Hui, B., et al., 2010. Biphasic modulation of cocaine-induced conditioned place preference through inhibition of histone acetyltransferase and histone deacetylase. Saudi Med. J. 31, 389-393.
22. Janak, P.H., Michael Gill, T., 2003. Comparison of the effects of allopregnanolone with direct GABAergic agonists on ethanol self-administration with and without concurrently available sucrose. Alcohol 30, 1-7.
23. Kalda, A., et al., 2007. Histone deacetylase inhibitors modulates the induction and expression of amphetamine-induced behavioral sensitization partially through an associated learning of the environment in mice (Netherlands). Behav. Brain Res. 181, 76-84.
24. Legastelois, R., et al., 2013. Blockade of ethanol-induced behavioral sensitization by sodium butyrate: descriptive analysis of gene regulations in the striatum. Alcohol Clin. Exp. Res. 37, 1143-1153.
25. Liljequist, S., Engel, J.A., 1984. Reversal of the anti-conflict action of valproate by various GABA and benzodiazepine antagonists. Life Sci. 34, 2525-2533.
26. Loscher, W., 2002. Basic pharmacology of valproate: A review after 35 years of clinical use for the treatment of epilepsy. CNS Drugs 16, 669-694.
27. Malvaez, M., et al., 2009. Epigenetic mechanisms underlying extinction of memory and drug-seeking behavior. Mamm Genome 20, 612-623.
28. Malvaez, M., et al., 2010. Modulation of chromatin modification facilitates extinction of cocaine-induced conditioned place preference. Biol. Psychiatry 67, 36-43.
29. Marks, P.A., 2010. Histone deacetylase inhibitors: A chemical genetics approach to understanding cellular functions. Biochim. Biophys. Acta 1799, 717-725.
30. Maze, I., Nestler, E.J., 2011. The epigenetic landscape of addiction. Ann. NY Acad. Sci. 1216, 99-113.
31. McQuown, S.C., Wood, M.A., 2010. Epigenetic regulation in substance use disorders. Curr. Psychiatry Rep. 12, 145-153.
32. Misiak, B., et al., 2013. The multidimensional nature of metabolic syndrome in schizophrenia: lessons from studies of one- carbon metabolism and DNA methylation. Epigenomics 5, 317-329.
33. Montalvo-Ortiz, J.L., et al., 2013. HDAC inhibitors restore the capacity of aged mice to respond to haloperidol through modulation of histone acetylation. Neuropsychopharmacology.
34. Moonat, S., et al., 2013. Aberrant histone deacetylase2-mediated histone modifications and synaptic plasticity in the amygdala predisposes to anxiety and alcoholism. Biol. Psychiatry 73, 763-773.
35. Narayan, P., Dragunow, M., 2010. Pharmacology of epigenetics in brain disorders. Br. J. Pharmacol. 159, 285-303.
36. Orru, A., et al., 2012. Operant, oral alcoholic beer self- Administration by C57BL/6J mice: effect of BHF177, a positive allosteric modulator of GABA(B) receptors. Psychopharmacology (Berl) 222, 685-700.
37. Pastor, V., et al., 2011. Histone deacetylase inhibition decreases preference without affecting aversion for nicotine. J. Neurochem. 116, 636-645.
38. Ramaker, M.J., et al., 2012. Effect of ganaxolone and THIP on operant and limited-access ethanol self-administration. Neuropharmacology 63, 555-564.
39. Raybuck, J.D., et al., 2013. The histone deacetylase inhibitor sodium butyrate modulates acquisition and extinction of cocaine-induced conditioned place preference. Pharmacol. Biochem. Behav. 106, 109-116.
40. Romieu, P., et al., 2011. The inhibition of histone deacetylases reduces the reinstatement of cocaine-seeking behavior in rats. Curr. Neuropharmacol. 9, 21-25.
41. Romieu, P., et al., 2008. Histone deacetylase inhibitors decrease cocaine but not sucrose self-administration in rats. J. Neurosci. 28, 9342-9348.
42. Sakharkar, A.J., et al., 2014. E ffects of histone deacetylase inhibitors on amygdaloid histone acetylation and neuropeptide Y expression: A role in anxiety-like and alcohol- drinking behaviours. Int. J. Neuropsychopharmacol., 1-14.
43. Sakharkar, A.J., et al., 2012. Histone deacetylases (HDAC)-induced histone modifications in the amygdala: A role in rapid tolerance to the anxiolytic effects of ethanol. Alcohol Clin. Exp. Res. 36, 61-71.
44. Steckert, A.V., et al., 2013. Effects of sodium butyrate on oxidative stress and behavioral changes induced by administration of D-AMPH. Neurochem. Int. 62, 425-432.
45. Stertz, L., et al., 2014. Histone deacetylase activity and brain- derived neurotrophic factor (BDNF) levels in a pharmacological model of mania. Rev Bras Psiquiatr. 36, 39-46.
46. Svrakic, D.M., et al., 2013. Risk architecture of schizophrenia: The role of epigenetics. Curr. Opin. Psychiatry. 26, 188-195.
47. Tanchuck, M.A., et al., 2011. Assessment of GABA-B, metabotropic glutamate, and opioid receptor involvement in an animal model of binge drinking. Alcohol 45, 33-44.
48. Vellucci, S.V., Webster, R.A., 1984. The role of GABA in the anticonflict action of sodium valproate and chlordiazepoxide. Pharmacol. Biochem. Behav. 21, 845-851.
49. Warnault, V., et al., 2013. Chromatin remodeling- A novel strategy to control excessive alcohol drinking. Transl. Psychiatry 3, e231.
50. Wolstenholme, J.T., et al., 2011. Genomic analysis of individual differences in ethanol drinking: evidence for non-genetic factors in C57BL/6 mice. PLoS One 6, e21100.
51. Wong, C.C., et al., 2011. Drugs and addiction: An introduction to epigenetics. Addiction 106, 480-489.
52. Zou, J.Y., Crews, F.T., 2014. Release of neuronal HMGB1 by ethanol through decreased HDAC activity activates brain neuroimmune signaling. PLoS One 9, e87915.